These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23361242)

  • 1. Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer.
    Ning J; Zhang J; Liu W; Lang Y; Xue Y; Xu S
    Eur J Histochem; 2012 Nov; 56(4):e46. PubMed ID: 23361242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
    Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
    Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
    Zhang Y; Yao L; Zhang X; Ji H; Wang L; Sun S; Pang D
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1245-53. PubMed ID: 21691749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma.
    Wang H; Li YP; Chen JH; Yuan SF; Wang L; Zhang JL; Yao Q; Li NL; Bian JF; Fan J; Yi J; Ling R
    Tumour Biol; 2013 Jun; 34(3):1635-9. PubMed ID: 23412977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.
    Dai W; Yao Y; Zhou Q; Sun CF
    PLoS One; 2014; 9(1):e87148. PubMed ID: 24466336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression.
    Sun T; Zhang K; Li W; Liu Y; Pangeni RP; Li A; Arvanitis L; Raz DJ
    Cell Commun Signal; 2022 Sep; 20(1):147. PubMed ID: 36123698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.
    Xu G; Cai J; Wang L; Jiang L; Huang J; Hu R; Ding F
    Exp Cell Res; 2018 Jan; 362(2):268-278. PubMed ID: 29174979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.
    Liang J; Zhang X; Xie S; Zhou X; Shi Q; Hu J; Wang W; Qi W; Yu R
    Med Oncol; 2014 Apr; 31(4):899. PubMed ID: 24573640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
    Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
    PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
    Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
    Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Surg Oncol; 2011 Mar; 103(3):283-9. PubMed ID: 21337558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma.
    Wang Z; Zhu L; Guo T; Wang Y; Yang J
    Hum Pathol; 2015 Jul; 46(7):1006-14. PubMed ID: 25971547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.
    Tang B; Liang X; Tang F; Zhang J; Zeng S; Jin S; Zhou L; Kudo Y; Qi G
    Int J Oncol; 2015 Dec; 47(6):2208-16. PubMed ID: 26497847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
    Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ
    Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma.
    Li J; Wang Z; Li Y
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1291-7. PubMed ID: 22447106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
    Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.
    Ding F; Bao C; Tian Y; Xiao H; Wang M; Xie X; Hu F; Mei J
    Int J Mol Sci; 2014 Dec; 16(1):307-20. PubMed ID: 25547493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
    Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
    Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.